231 related articles for article (PubMed ID: 31484723)
1. Relative stabilities of wild-type and mutant glial fibrillary acidic protein in patients with Alexander disease.
Heaven MR; Wilson L; Barnes S; Brenner M
J Biol Chem; 2019 Oct; 294(43):15604-15612. PubMed ID: 31484723
[TBL] [Abstract][Full Text] [Related]
2. Glial fibrillary acidic protein exhibits altered turnover kinetics in a mouse model of Alexander disease.
Moody LR; Barrett-Wilt GA; Sussman MR; Messing A
J Biol Chem; 2017 Apr; 292(14):5814-5824. PubMed ID: 28223355
[TBL] [Abstract][Full Text] [Related]
3. Plectin regulates the organization of glial fibrillary acidic protein in Alexander disease.
Tian R; Gregor M; Wiche G; Goldman JE
Am J Pathol; 2006 Mar; 168(3):888-97. PubMed ID: 16507904
[TBL] [Abstract][Full Text] [Related]
4. The Alexander disease-causing glial fibrillary acidic protein mutant, R416W, accumulates into Rosenthal fibers by a pathway that involves filament aggregation and the association of alpha B-crystallin and HSP27.
Der Perng M; Su M; Wen SF; Li R; Gibbon T; Prescott AR; Brenner M; Quinlan RA
Am J Hum Genet; 2006 Aug; 79(2):197-213. PubMed ID: 16826512
[TBL] [Abstract][Full Text] [Related]
5. Site-specific phosphorylation and caspase cleavage of GFAP are new markers of Alexander disease severity.
Battaglia RA; Beltran AS; Delic S; Dumitru R; Robinson JA; Kabiraj P; Herring LE; Madden VJ; Ravinder N; Willems E; Newman RA; Quinlan RA; Goldman JE; Perng MD; Inagaki M; Snider NT
Elife; 2019 Nov; 8():. PubMed ID: 31682229
[TBL] [Abstract][Full Text] [Related]
6. Pexidartinib treatment in Alexander disease model mice reduces macrophage numbers and increases glial fibrillary acidic protein levels, yet has minimal impact on other disease phenotypes.
Boyd MM; Litscher SJ; Seitz LL; Messing A; Hagemann TL; Collier LS
J Neuroinflammation; 2021 Mar; 18(1):67. PubMed ID: 33685480
[TBL] [Abstract][Full Text] [Related]
7. Oligomers of mutant glial fibrillary acidic protein (GFAP) Inhibit the proteasome system in alexander disease astrocytes, and the small heat shock protein alphaB-crystallin reverses the inhibition.
Tang G; Perng MD; Wilk S; Quinlan R; Goldman JE
J Biol Chem; 2010 Apr; 285(14):10527-37. PubMed ID: 20110364
[TBL] [Abstract][Full Text] [Related]
8. Elevated GFAP induces astrocyte dysfunction in caudal brain regions: A potential mechanism for hindbrain involved symptoms in type II Alexander disease.
Minkel HR; Anwer TZ; Arps KM; Brenner M; Olsen ML
Glia; 2015 Dec; 63(12):2285-97. PubMed ID: 26190408
[TBL] [Abstract][Full Text] [Related]
9. Suppression of GFAP toxicity by alphaB-crystallin in mouse models of Alexander disease.
Hagemann TL; Boelens WC; Wawrousek EF; Messing A
Hum Mol Genet; 2009 Apr; 18(7):1190-9. PubMed ID: 19129171
[TBL] [Abstract][Full Text] [Related]
10. STAT3 Drives GFAP Accumulation and Astrocyte Pathology in a Mouse Model of Alexander Disease.
Hagemann TL; Coyne S; Levin A; Wang L; Feany MB; Messing A
Cells; 2023 Mar; 12(7):. PubMed ID: 37048051
[TBL] [Abstract][Full Text] [Related]
11. Aggregation-prone GFAP mutation in Alexander disease validated using a zebrafish model.
Lee SH; Nam TS; Kim KH; Kim JH; Yoon W; Heo SH; Kim MJ; Shin BA; Perng MD; Choy HE; Jo J; Kim MK; Choi SY
BMC Neurol; 2017 Sep; 17(1):175. PubMed ID: 28882119
[TBL] [Abstract][Full Text] [Related]
12. Elevated GFAP isoform expression promotes protein aggregation and compromises astrocyte function.
Lin NH; Yang AW; Chang CH; Perng MD
FASEB J; 2021 May; 35(5):e21614. PubMed ID: 33908669
[TBL] [Abstract][Full Text] [Related]
13. Alexander disease-associated glial fibrillary acidic protein mutations in mice induce Rosenthal fiber formation and a white matter stress response.
Hagemann TL; Connor JX; Messing A
J Neurosci; 2006 Oct; 26(43):11162-73. PubMed ID: 17065456
[TBL] [Abstract][Full Text] [Related]
14. Synemin is expressed in reactive astrocytes and Rosenthal fibers in Alexander disease.
Pekny T; Faiz M; Wilhelmsson U; Curtis MA; Matej R; Skalli O; Pekny M
APMIS; 2014 Jan; 122(1):76-80. PubMed ID: 23594359
[TBL] [Abstract][Full Text] [Related]
15. Autophagy induced by Alexander disease-mutant GFAP accumulation is regulated by p38/MAPK and mTOR signaling pathways.
Tang G; Yue Z; Talloczy Z; Hagemann T; Cho W; Messing A; Sulzer DL; Goldman JE
Hum Mol Genet; 2008 Jun; 17(11):1540-55. PubMed ID: 18276609
[TBL] [Abstract][Full Text] [Related]
16. A report of two cases of bulbospinal form Alexander disease and preliminary exploration of the disease.
Song X; Jiang J; Tian W; Zhan F; Zhu Z; Li B; Tang H; Cao L
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34109421
[TBL] [Abstract][Full Text] [Related]
17. Mutations in GFAP Disrupt the Distribution and Function of Organelles in Human Astrocytes.
Jones JR; Kong L; Hanna MG; Hoffman B; Krencik R; Bradley R; Hagemann T; Choi J; Doers M; Dubovis M; Sherafat MA; Bhattacharyya A; Kendziorski C; Audhya A; Messing A; Zhang SC
Cell Rep; 2018 Oct; 25(4):947-958.e4. PubMed ID: 30355500
[TBL] [Abstract][Full Text] [Related]
18. Aggregate formation analysis of GFAP
Tulyeu J; Tamaura M; Jimbo E; Shimbo H; Takano K; Iai M; Yamashita S; Goto T; Aida N; Tokuhiro E; Yamagata T; Osaka H
Brain Dev; 2019 Feb; 41(2):195-200. PubMed ID: 30213442
[TBL] [Abstract][Full Text] [Related]
19. The origin of Rosenthal fibers and their contributions to astrocyte pathology in Alexander disease.
Sosunov AA; McKhann GM; Goldman JE
Acta Neuropathol Commun; 2017 Mar; 5(1):27. PubMed ID: 28359321
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of mutated GFAP aggregates revealed by real-time imaging of an astrocyte model of Alexander disease.
Mignot C; Delarasse C; Escaich S; Della Gaspera B; Noé E; Colucci-Guyon E; Babinet C; Pekny M; Vicart P; Boespflug-Tanguy O; Dautigny A; Rodriguez D; Pham-Dinh D
Exp Cell Res; 2007 Aug; 313(13):2766-79. PubMed ID: 17604020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
